(Q42666923)
Statements
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial (English)
Kate Fife
Tim Eisen
Paul D Nathan
Peter G Harper
Steve Nicholson
Amit Bahl
Piotr Tomczak
Seppo Pyrhonen
Jane Boxall
Andrea Wagner
Michael Jeffers
6 September 2012